The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
about
Ion channel clustering at the axon initial segment and node of Ranvier evolved sequentially in early chordatesSodium channel blockers for neuroprotection in multiple sclerosisSodium channel blockers for neuroprotection in multiple sclerosisHigh-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analoguesModifications of antiepileptic drugs for improved tolerability and efficacyEfficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic painDiverse mechanisms of antiepileptic drugs in the development pipelineMolecular targets for antiepileptic drug developmentTreatment of Generalized Convulsive Status Epilepticus in Pediatric PatientsDepression and anxiety in people with epilepsyTreatment of anxiety disorders in epilepsy: an evidence-based approachThe riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant.Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.Current Status of the New Antiepileptic Drugs in Chronic PainStructural determinants for branched-chain aminotransferase isozyme-specific inhibition by the anticonvulsant drug gabapentinMajor channels involved in neuropsychiatric disorders and therapeutic perspectivesNew developments in the pharmacotherapy of cocaine abuseThe effectiveness of anticonvulsants in psychiatric disordersLacosamide: a new approach to target voltage-gated sodium currents in epileptic disordersOtoprotective effects of ethosuximide in NOD/LtJ mice with age-related hearing lossSynthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent.TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase.A Drosophila systems model of pentylenetetrazole induced locomotor plasticity responsive to antiepileptic drugs.Phenytoin normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats.The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended ImmunotherapiesClinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.VEP indices of cortical lateral interactions in epilepsy treatment.Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in mice.Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.Drug resistance in brain diseases and the role of drug efflux transporters.Pretreatment with intrathecal amitriptyline potentiates anti-hyperalgesic effects of post-injury intra-peritoneal amitriptyline following spinal nerve ligationMolecular targets versus models for new antiepileptic drug discoveryConverging genetic and functional brain imaging evidence links neuronal excitability to working memory, psychiatric disease, and brain activity.Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization.Use of antiepileptic drugs for hyperkinetic movement disorders.Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
P2860
Q21145023-3204C44E-8D3F-4C20-8694-DB469945AC48Q24186448-899F27B9-D864-46EA-9C74-26E5E457A7DAQ24200461-37067255-628B-45D5-ADE9-B5132D809D40Q24649751-2B1E9369-5D84-4A69-8962-72932B7048DEQ24651951-5AE3AE13-86B7-4509-A929-FCE11C76A7AAQ24670430-B51A9FB0-4E2F-41AF-B9F7-503171D0CF00Q24675330-2C227045-FA6C-4117-A4AA-4BBFE0F0F3F2Q24683346-188E1CEB-648D-4867-A998-FE74C83181CAQ26783899-1A36D906-E90D-4FBB-BBCC-339AA948BBA6Q27008273-223C3A5A-E265-4ACD-926B-696367FAD4EFQ27013563-75318AF4-8D01-4395-87E4-2CEAF1283BF2Q27339255-A32C54B0-0A34-46ED-86AA-E65BD8725038Q27693823-F4F3C827-D800-45EB-B908-0FBA531AC0CBQ28070254-A5CCE116-EB3D-4A33-AB6B-F3B1FE848B24Q28115621-8FBA5A8C-D01C-4029-8F72-8F435A56688FQ28290639-83781127-1A80-42A4-B280-129E3BDCCA31Q28302782-CCF740A2-8A95-4696-90BF-EA5EAB8C3AB8Q28744504-1C781B85-DB6D-4A09-AEC7-293AA54CDFDDQ28833549-11183242-E77A-4617-8DA7-95A730DF7DABQ30354158-85E89C1B-6391-4841-9F45-FAAADD2951D6Q30411736-71855487-4BF8-48F2-A02B-0A3704C9BB6EQ30424352-A45AA49D-40FE-417B-8457-FB0D0F1434AAQ30465622-0E2D8DBE-39AB-4B17-A113-608F6D3CEDD8Q30486566-5A79A7D0-B35C-4621-AC71-120D44466BF8Q30499630-FBF535F0-335D-498A-BBCC-A62F8A84EB45Q30576758-F4550618-6FAE-431A-9B09-E53B5CBF0083Q30577314-0162A9E3-E61D-4E7F-832B-6BA45253D12AQ33600142-71289267-E2FB-4780-97FB-484DF54A0AC9Q33610934-4649CC06-4721-4097-9FCD-7C02709CC0E4Q33864984-6F54D74E-ED6F-4936-95C4-01B20ADF8D5FQ33923266-B9684E1C-6CB3-4E7A-AB3A-82FA22A0090BQ33985133-5098D5E8-51B8-42C5-870A-3EA730A6A2E4Q33988704-EC133C8A-65EE-4EE5-B5FC-DC53B42C15FEQ34312671-E0EEA865-CD0D-4ED0-8445-AE2900D003C4Q34375049-194CC49D-44A1-4130-B17A-DF528A0BC75BQ34381880-142F8EA4-460A-4F95-8061-ACA172062F1DQ34458158-A5627F14-0328-4B56-ADFF-BB84089CAA0EQ34460610-CE5F35C4-DFBB-49BD-8328-6FD2B07A108AQ34829294-EEAA682E-063A-42FD-9069-5265B6B7270EQ34942400-261526C3-FCC1-4FE7-8B24-62BD14617CF2
P2860
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
@ast
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
@en
type
label
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
@ast
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
@en
prefLabel
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
@ast
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.
@en
P2860
P356
P1433
P1476
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
@en
P2093
Wolfgang Löscher
P2860
P2888
P304
P356
10.1038/NM1074
P407
P577
2004-07-01T00:00:00Z